|
|
|
|
|
|
|
|
|
08.10.25 - 13:03
|
Exact Sciences Schedules Third Quarter 2025 Earnings Call (Business Wire)
|
|
|
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company plans to release its third quarter 2025 financial results after the close of the U.S. financial markets on November 3, 2025. Following the release, company management will host a webcast and conference call at 5 p.m. ET to discuss financial results and business progress.
Third quarter 2025 webcast & conference call details
Date:
Monday, November 3, 2025
Time:
5 p.m. ET
Webcast:
The live webcast can be accessed at www.exactsciences.com
Telephone:
Domestic callers, dial 888-330-2384
International callers, dial +1 240-789-2701
Access code for both domestic and international callers: 4437608
A replay of the webcast will be available at www.exactsciences.com. The webcast, conference call, and replay are open to all interested parties.
About Exact Sciences Corp.
A leading provider of cancer screening and diagnostic tests, Exact Sciences (Nasdaq: EXAS)...
|
|
|
|
|
02.10.25 - 22:06
|
What Analysts Are Saying About Exact Sciences Stock (Benzinga)
|
|
|
Latest Ratings for EXAS
DateFirmActionFromTo Feb 2022Wells FargoMaintainsEqual-Weight Feb 2022CitigroupMaintainsNeutral Feb 2022Raymond JamesMaintainsOutperform
View More Analyst Ratings for EXAS
View the Latest Analyst Ratings
read more...
|
|
|
|
|
|
|
15.09.25 - 20:12
|
Should Companies Drop Quarterly Reports? Joe Weisenthal Weighs in | Open Interest 9/15/2025 (Bloomberg)
|
|
|
Get a jump start on the US trading day with Matt Miller and Dani Burger on "Bloomberg Open Interest." President Trump said companies should not be forced to deliver earnings reports quarterly, saying he preferred a six-month schedule because it saved businesses time and money. Odd Lots Co-Host Joe Weisenthal joined us with his insights on the proposal. Meanwhile, Elon Musk bought about $1B worth of Tesla shares. And Alphabet joined an elite group of companies valued at more than $3 trillion. Exact Sciences CEO Kevin Conroy joined Open Interest in the C-Suite to talk about the company's new blood test that can detect over 50 types of cancers. (Source: Bloomberg)...
|
|
|
|
|
15.09.25 - 17:12
|
Exact Sciences CEO on Launch of Multi-Cancer Blood Test (Bloomberg)
|
|
|
Exact Sciences CEO and Chair Kevin Conroy discusses the company's new multi-cancer blood test and competitive environment. Speaking on "Bloomberg Open Interest," Conroy also comments on President Donald Trump's view that companies should report earnings every six months. (Source: Bloomberg)...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
